{"id":"https://genegraph.clinicalgenome.org/r/f6b02529-894d-4983-b90b-795003ca79f9v1.0","type":"EvidenceStrengthAssertion","dc:description":"ATCAY encodes for Caytaxin, a neuronally restricted protein that is expressed specifically in the hippocampus, cortex, cerebellum, and olfactory bulb (PMID: 17157273), where it recruits cholinergic machinery to neurite terminals to promote acetylcholine signaling and neuritogenesis (PMID: 26343454).\n\nATCAY was first reported in relation to Cayman Ataxia, due a high frequency of this disorder in a highly inbred area of Grand Cayman Island (PMID: 14556008).  It is characterized by prominent cerebellar dysfunction (ataxia, nystagmus, intention tremor, dysarthria), psychomotor retardation, and cerebellar hypoplasia. Genomic variants in this gene have been reported outside of the Cayman Island (PMIDs: 29449188, 33624863), therefore, all phenotypes listed above have been grouped as one disease entity: Cerebellar ataxia (MONDO: 0000437). \n\nEvidence supporting this gene-disease relationship includes case-level data and experimental evidence. Summary of Case Level Data: 8 POINTS. This curation has 2 non-sense variants and one splice site variant in 3 unrelated probands from 3 publications (PMIDs: 14556008, 29449188, 33624863 ). This gene-disease association is supported by mouse models harboring ATCAY variants (jittery, sidewinder) that display an early onset ataxia that can be rescued with the expression of wild type human caytaxin (PMID: 23226316). \n\nIn summary, there is DEFINITIVE evidence to support this gene-disease relationship. No convincing contradictory evidence has emerged. This classification was approved by the ClinGen Cerebral Palsy Gene Curation Expert Panel on 02/20/2023 (SOP Version 9).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f6b02529-894d-4983-b90b-795003ca79f9","GCISnapshot":"https://genegraph.clinicalgenome.org/r/bcbe54f9-71d2-4aac-b240-e84e78b67b76","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/bcbe54f9-71d2-4aac-b240-e84e78b67b76_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":"2023-05-23T19:37:17.779Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/bcbe54f9-71d2-4aac-b240-e84e78b67b76_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":"2023-02-20T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bcbe54f9-71d2-4aac-b240-e84e78b67b76_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bcbe54f9-71d2-4aac-b240-e84e78b67b76_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ec647a6-d421-4355-a001-52b87ddc59a9","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efee3571-79c8-45b1-83d3-9919e1559884","type":"Finding","dc:description":"Ataxia occurs in both mice and humans affected by biallelic variants in the ATCAY gene","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14556008","rdfs:label":"Jittery mice model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5b8ed6f7-b9de-4e38-b456-3fb33c027c9f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c56552e4-6108-4970-b54c-27cad7aa605e","type":"Finding","dc:description":"Mice containing the human ATCAY BAC on an ATCAY mutant background exhibited no visible signs of ataxia or dystonia, no difficulties assessing food or water, successfully bred and reared offspring, and lived beyond 1.5 years without gait disturbances.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23226316","rdfs:label":"Human ATCAY DNA rescue ataxic ATCAY mouse mutants","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/bcbe54f9-71d2-4aac-b240-e84e78b67b76_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea52f3e7-24b7-432a-bdd2-0d4d7742ac1c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34c8f5fd-34b3-481a-8bb2-bc286eae3817","type":"EvidenceLine","dc:description":"The splice variant fails to promote neurite outgrowth in rat adrenal pheochromocytoma cells. The missense variant p. Ser301Arg segregated within the family but was not scored because it does not impair neurite outgrowth according to recent evidence (PMID 26343454)","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34c8f5fd-34b3-481a-8bb2-bc286eae3817_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Bomar et al. reported that individuals with Cayman ataxia have two homozygous variants in ATCAY, one the missense variant S301R, and the other a splice site on intron 9. Sun et al. (PMID 26343454) reported that both the splice variant alone and the hybrid mutant protein failed to promote neurite outgrowth in rat adrenal pheochromocytoma cells, whereas the missense variant alone did not. The author concluded that Cayman ataxia is caused by the splicing but not the missense variant.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/34c8f5fd-34b3-481a-8bb2-bc286eae3817_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14556008","allele":{"id":"https://genegraph.clinicalgenome.org/r/05fe0715-a020-4cd8-bdd5-a9e588254226","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033064.5(ATCAY):c.965+3G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2319116383"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/ea52f3e7-24b7-432a-bdd2-0d4d7742ac1c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14556008","rdfs:label":"Highly Inbred Cayman Island family","allele":{"id":"https://genegraph.clinicalgenome.org/r/05fe0715-a020-4cd8-bdd5-a9e588254226"},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"Ataxic gait\nNystagmus\nDysarthria\nIntention tremor\nPsychomotor retardation","secondTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/34c8f5fd-34b3-481a-8bb2-bc286eae3817_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/44476edf-3d73-45c2-b5ca-44ba491d16b3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/621fc696-3169-4f3c-a2b2-bffc58dd4434","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/621fc696-3169-4f3c-a2b2-bffc58dd4434_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33624863","allele":{"id":"https://genegraph.clinicalgenome.org/r/e04d0e49-969c-448b-a07a-d18f404a6902","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033064.5(ATCAY):c.570C>G (p.Ala190=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA504982333"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/44476edf-3d73-45c2-b5ca-44ba491d16b3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33624863","rdfs:label":"ATCAY proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/e04d0e49-969c-448b-a07a-d18f404a6902"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Ataxia\nOculomotor apraxia\nCognitive impairment\nPsychomotor retardation","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/621fc696-3169-4f3c-a2b2-bffc58dd4434_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/e9808cd4-804d-44c2-bc05-c80491e9ff94_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/bcbe54f9-71d2-4aac-b240-e84e78b67b76_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b09eb44-446e-4a28-b0ad-e35c03f74ff9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29449188","rdfs:label":"RDHR-04","estimatedLodScore":4.03,"family":{"id":"https://genegraph.clinicalgenome.org/r/8b09eb44-446e-4a28-b0ad-e35c03f74ff9","type":"Family","rdfs:label":"RDHR-04","ethnicity":{"id":"cg:UnknownEthnicity"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Sever Ataxia\nMuscular atrophy\nHypomimia\nPes planus\nBradykinesia","phenotypeNegativeAlleleNegative":13,"phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e9808cd4-804d-44c2-bc05-c80491e9ff94"},"publishedLodScore":3.29,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8}],"evidenceStrength":"Definitive","sequence":6263,"specifiedBy":"GeneValidityCriteria9","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/51UjvKL45X4","type":"GeneValidityProposition","disease":"obo:MONDO_0000437","gene":"hgnc:779","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_bcbe54f9-71d2-4aac-b240-e84e78b67b76-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}